Dental Cleaning to Prevent Chronic Graft-Versus-Host Disease
Part of paid clinical trials in Seattle, Washington.
- Sponsor
- Fred Hutchinson Cancer Center
- Study ID
- NCT07535008
- Status
- Recruiting
Conditions
- Acute Graft Versus Host Disease
- Chronic Graft Versus Host Disease
- Hematopoietic and Lymphatic System Neoplasm
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Dental Cleaning — PROCEDUREDental cleaning
- Dental Plaque sampling — PROCEDUREAncillary studies
Study Details
This clinical trial evaluates the feasibility and effectiveness of a post-transplant dental cleaning for the prevention of chronic graft versus host disease (GVHD) in patients undergoing an allogeneic hematopoietic cell transplant (HCT). HCT is the only curative treatment for some types of blood cancer. Unfortunately, this approach can lead to the development of GVHD, which is a disease caused when cells from a donated stem cell graft attack the normal tissue of the transplant patient. Some research has shown that the bacteria that is present in the dental plaque soon after transplant may affect the development of chronic GVHD. Dental cleanings prior to transplant are part of the normal standard of care for patients undergoing HCT. Adding an additional cleaning shortly after HCT may be effective for preventing the development of chronic GVHD.
Key Dates
- Start date
- Jun 15, 2026
- Status verified
- Apr 2026
- Primary completion
- Apr 30, 2028
- Completion
- Apr 30, 2029
Study Design
- Enrollment
- 45 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- PREVENTION
Arms
- Experimental: Prevention (dental cleaning)Patients undergo simplified dental cleaning on day +28 following HCT.
Primary Outcome Measure
Probability of moderate-to-severe chronic graft versus host disease [ Time Frame: At 1-year post-transplant ]
Central Contacts
- Armin Rashidi, MD, PhD206-667-2506
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Fred Hutch/University of Washington Cancer Consortium | Seattle | Washington | 98109 | Armin Rashidi, MD, PhD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Seattle, WA
Related Studies
- A Long-term Extension Study of PCI-32765 (Ibrutinib)PHASE3 · Recruiting · Janssen Research & Development, LLC · Duarte, California
- Collection and Storage of Tissue and Blood Samples From Patients With CancerRecruiting · National Cancer Institute LAO · Birmingham, Alabama
- Predicting the Quality of Response to Specific Treatments in Patients With cGVHD, PQRST StudyRecruiting · Fred Hutchinson Cancer Center · Gainesville, Florida
- Sustained Oral Fiber Supplementation for Patients Undergoing Donor Stem Cell Transplantation for Hematological MalignanciesRecruiting · Fred Hutchinson Cancer Center · Seattle, Washington